TPP REGULATIONS COULD HINDER ACCESS TO MEDICINE FOR EVOLVING ECONOMIES
January 7th, 2015
INTELLECTUAL property regulations proposed during the ongoing Trans-Pacific Partnership (TPP) negotiations could hinder access to medicine in developing countries, a law professor at the University of Sydney, Australia, who specialises in trade agreements and intellectual property (IP) issues has told Manufacturing Chemist.Prof Kimberlee Weatherall said regulations sparked by a TPP deal could make it more difficult for developed countries to help developing countries have “an effective public response as health issues and medicines evolve.”According to Prof ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.